Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study | Zendy

Markus Juonala | Zendy; Jorma Viikari | Zendy; Georg Alfthan | Zendy; Jukka Marniemi | Zendy; Mika Kähönen | Zendy; Leena Taittonen | Zendy; Tomi Laitinen | Zendy; Olli T. Raitakari | Zendy

Open Access

Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study

Author(s) -

Markus Juonala,

Jorma Viikari,

Georg Alfthan,

Jukka Marniemi,

Mika Kähönen,

Leena Taittonen,

Tomi Laitinen,

Olli T. Raitakari

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.690016

Subject(s) - brachial artery , medicine , cardiology , asymmetric dimethylarginine , risk factor , population , endothelium , univariate analysis , endothelial dysfunction , renal function , endocrinology , blood pressure , arginine , multivariate analysis , biochemistry , chemistry , environmental health , amino acid

Elevated asymmetrical dimethylarginine (ADMA) is a novel risk factor for atherosclerosis that may impair endothelial function by interfering with endothelial nitric oxide synthesis. To gain insight into the effects of ADMA on systemic endothelial function, we examined the association between ADMA and brachial artery flow-mediated dilation (FMD) in a large population of young adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research